UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Seoul metro region remain as Covid-19 hotspot
Korea's new virus cases dipped below 50 on Thursday, but cluster infect...
by Lee Han-soo
|
2020-07-24 13:09
라인
'Eylea T&E therapy ideal in treating wAMD'
Wet age-related macular degeneration (wAMD), the top cause of blindness for...
by Lee Han-soo
|
2020-07-24 11:29
라인
Samsung Bioepis' 1H biosimilar sales in EU top $390 million
Samsung Bioepis' biosimilar sales in European Union surpassed $390 mill...
by Lee Han-soo
|
2020-07-23 17:57
라인
'Untreated shingles can increase risk of dementia'
A research team at Asan Medical Center has confirmed that if patients suffe...
by Lee Han-soo
|
2020-07-23 15:27
라인
LegoChem names China’s WuXi AppTec as provider of non-clinical trial service
LegoChem Bioscience said that it has designated WuXi AppTec, a Chinese cont...
by Lee Han-soo
|
2020-07-23 15:21
라인
New virus cases stay around 60
Korea's new Covid-19 cases remained around 60 on Thursday, as outbreaks...
by Lee Han-soo
|
2020-07-23 14:12
라인
Koreans lack awareness of varicose vein disease
A majority of Koreans are unaware of serious complications that could occur...
by Lee Han-soo
|
2020-07-22 17:43
라인
Genexine scores FDA nod for trials of GX-I7 combination therapy
Genexine has received U.S. Food and Drug Administration’s approval to condu...
by Lee Han-soo
|
2020-07-22 17:43
라인
Myongji Hospital opens multiperson hyperbaric oxygen therapy center
Myongji Hospital said it has opened the first multiperson hyperbaric oxygen...
by Lee Han-soo
|
2020-07-22 14:44
라인
AZ selects SK Bioscience as global supplier of Covid-19 vaccine
AstraZeneca said that it has inked a deal with SK Bioscience, an SK Chemica...
by Lee Han-soo
|
2020-07-22 12:15
라인
GC sells off North America business to Grifols
GC said that it has sold off its Montreal-based GC Biotherapeutics’ plasma ...
by Lee Han-soo
|
2020-07-21 18:31
라인
Helixmith to start trials of VM202 for treating rare disorder
Helixmith said that it has kicked off its phase 1 and 2a clinical trial for...
by Lee Han-soo
|
2020-07-21 17:10
라인
Genexine, Y Biologics to co-develop Covid-19 treatment
Genexine said that it would develop an antibody-based Covid-19 treatment, j...
by Lee Han-soo
|
2020-07-21 15:52
라인
Cluster infections at adult daycare facility push back new virus cases
New virus cases bounced back above 40 on Monday, as a daycare facility for ...
by Lee Han-soo
|
2020-07-21 14:18
라인
'Diabetes independent risk factor for severe, critical Covid-19 outcomes’
Researchers at Yeungnam University Medical Center have found that diabetes ...
by Lee Han-soo
|
2020-07-17 17:44
라인
Celltrion’s Covid-19 diagnostic kit gets CE certification
Celltrion said that its Covid-19 antigen diagnostic kit has won EU’s Confor...
by Lee Han-soo
|
2020-07-17 15:39
라인
New virus cases hover around 60
Korea’s new Covid-19 cases stayed around 60 for the second straight day on ...
by Lee Han-soo
|
2020-07-17 12:45
라인
‘Obese people more vulnerable to Covid-19’
A researcher at Seoul National University Bundang Hospital and the compilin...
by Lee Han-soo
|
2020-07-16 17:30
라인
SNUH develops new nanoparticle to improve hyperthermia treatment for cancer
A research team at the Seoul National University Hospital (SNUH) has develo...
by Lee Han-soo
|
2020-07-16 16:39
라인
Genbody to export 2nd Covid-19 diagnostic kit
Genbody said Thursday that it will launch "GenBody COVID-19 Ag," a rapid an...
by Lee Han-soo
|
2020-07-16 14:39
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top